Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML

Overview of attention for article published in Leukemia, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

GSBS Therapeutics & Pharmacology Program, 27 Dec 2018

Small molecule inhibition of beta-catenin (lead compound of local Houston biotech Beta Cat) and PROTAC degradation of…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.